Current Oncology (Jul 2024)

Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review

  • Agnieszka Namysl-Kaletka,
  • Jerzy Wydmanski,
  • Iwona Debosz-Suwinska,
  • Malgorzata Kaszuba,
  • Dorota Gabrys,
  • Agata Roch-Zniszczol,
  • Daria Handkiewicz-Junak

DOI
https://doi.org/10.3390/curroncol31070307
Journal volume & issue
Vol. 31, no. 7
pp. 4123 – 4132

Abstract

Read online

Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for surgery, while in those operated on, the risk of perioperative complications is up to 30%. Diazoxide treatment to prevent hypoglycemia is effective only in 50% of patients. To prevent tumor growth and hormonal excess, stereotactic radiotherapy may be an alternative to surgical treatment. In our paper, we present two cases of patients with insulinoma treated successfully with stereotactic body radiation therapy (SBRT).

Keywords